about
Epidemiology and clinical course of Crohn's disease: results from observational studiesThe Role of MR Enterography in Assessing Crohn's Disease Activity and Treatment ResponsePromising biological therapies for ulcerative colitis: A review of the literatureAntioxidant therapy for treatment of inflammatory bowel disease: Does it work?Inflammatory Bowel Disease: An Overview of Immune Mechanisms and Biological TreatmentsEosinophils in Gastrointestinal Disorders: Eosinophilic Gastrointestinal Diseases, Celiac Disease, Inflammatory Bowel Diseases, and Parasitic InfectionsEndoplasmic reticulum stress and inflammationShining a light on intestinal trafficA review of the impact of biologics on surgical complications in Crohn's diseaseClinical use and mechanisms of infliximab treatment on inflammatory bowel disease: a recent updateInflammatory pathways of importance for management of inflammatory bowel diseaseChemokines and chemokine receptors: update on utility and challenges for the clinician.Serum amino acids profile and the beneficial effects of L-arginine or L-glutamine supplementation in dextran sulfate sodium colitisMycophenolate Mofetil Modulates Differentiation of Th1/Th2 and the Secretion of Cytokines in an Active Crohn's Disease Mouse ModelUltrasound-based molecular imaging and specific gene delivery to mesenteric vasculature by endothelial adhesion molecule targeted microbubbles in a mouse model of Crohn's disease.Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritisMacrophages require Skap2 and Sirpα for integrin-stimulated cytoskeletal rearrangement.Limitations in assessment of mucosal healing in inflammatory bowel diseaseImplications of genome-wide association studies in novel therapeutics in primary biliary cirrhosisGenetic regulation of serum cytokines in systemic lupus erythematosusSynergy of Transforming Growth Factor Beta 1 and All Trans Retinoic Acid in the Treatment of Inflammatory Bowel Disease: Role of Regulatory T cells.The safety of infliximab infusions in the community settingAlternative medicines as emerging therapies for inflammatory bowel diseases.Resolvin E1-induced intestinal alkaline phosphatase promotes resolution of inflammation through LPS detoxification.Pulmonary manifestations of inflammatory bowel diseaseInflammatory bowel disease-associated interleukin-33 is preferentially expressed in ulceration-associated myofibroblasts.Gender and the treatment of immune-mediated chronic inflammatory diseases: rheumatoid arthritis, inflammatory bowel disease and psoriasis: an observational study.Pulmonary manifestations of Crohn's disease.Crohn's disease: the first visitInvolvement of MAPK/NF-κB signaling in the activation of the cholinergic anti-inflammatory pathway in experimental colitis by chronic vagus nerve stimulationButein effects in colitis and interleukin-6/signal transducer and activator of transcription 3 expression.Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation.Role of tumor necrosis factor-α in the extraintestinal thrombosis associated with colonic inflammation.Dendritic cell SIRT1-HIF1α axis programs the differentiation of CD4+ T cells through IL-12 and TGF-β1.Development of a pH-responsive particulate drug delivery vehicle for localized biologic therapy in inflammatory bowel diseaseAn integrin alpha4beta7•IgG heterodimeric chimera binds to MAdCAM-1 on high endothelial venules in gut-associated lymphoid tissueOral mixture of autologous colon-extracted proteins for the Crohn's disease: A double-blind trialThe Endoplasmic Reticulum Stress Sensor IRE1α in Intestinal Epithelial Cells Is Essential for Protecting against Colitis.BALB/c-Fcgr2bPdcd1 mouse expressing anti-urothelial antibody is a novel model of autoimmune cystitis.A phase II study of laquinimod in Crohn's disease.
P2860
Q22241217-2D8C5FE4-3EAB-4AFA-9B21-4462C8260B7EQ26773129-D2A0A205-200F-4C21-8747-266CEA5ABFFCQ26776139-A375177A-AB3E-4BB2-A3D7-45498718B75DQ26777641-0C161C51-B082-4BFB-8249-4A87F35CC810Q26785537-BAE4979D-1F9A-4CFF-A30F-C6DC4FC883CAQ26799615-9F03B96A-0668-4AC8-8317-89640CEB690BQ26825586-EAD55A39-58FD-4298-9EB1-780DCA20AD96Q26863227-DB648A6E-47CB-4A1E-8602-2AFCB96E5058Q26865009-58B58BD7-EE1E-4511-AE73-CBA6F5E795EFQ26994776-D390091A-B28D-480B-8196-25C8A407FD84Q27005445-D5A0E7DB-F030-4270-A999-F48D4CBFDC05Q27687402-7521F63A-0AF7-4F2A-9177-F8302BD68A29Q28539583-ABAB593C-68D6-47BD-82B6-FF3DB02BED56Q30386671-491502B2-3D5C-480D-B61D-167D302D0F7FQ30414837-290F1A76-0F7C-46C1-8EED-4CC30B805CFEQ30434426-F79E993D-18E9-45CC-A019-11F56938865AQ30533919-F5E2EB60-1853-47F0-A179-22E9CB73D5C8Q33564957-65417261-9EAB-4EA4-8AF1-89E2A40E0990Q33579196-D4E9E55C-0F52-4CBD-9417-5751B9486FC2Q33682879-6E39CA3A-0620-4C49-AE92-B30979674769Q33772861-7E3F894E-3C34-480C-A48D-0573A67DD1A6Q33916750-16879ED6-EF62-4680-8F58-A674E2AEB22DQ34069427-A324B052-D92E-4CD7-863A-5EA5250710A4Q34069514-D5EEA7D8-7538-4A60-B460-F297787FC736Q34303009-BF5A61FD-B549-409E-B4BA-E94502ED6C22Q34358060-89AEADF7-0FF9-4545-A134-4829DDC5C07DQ34361748-76836869-84F2-4DCA-AEF4-421E1451A674Q34397357-EACADC33-6F10-4EB7-A259-FAF6F0267B69Q34811529-94E11B82-FF2B-4975-B54D-8AFB777428A5Q34924354-D3EF980C-57B7-4388-A1A3-AE785C32FADEQ34932421-EF606B34-710C-4A9F-B9B3-FFEFF21BC3EDQ35012024-F91FD6E6-0D72-4EE3-85A5-BF30AF111DDFQ35069554-11E29BA2-EC17-4CBE-88AA-70F285220D18Q35156962-1B39B2E7-FCBE-43FD-97EA-4BBDE57CE772Q35228674-7572FD27-4226-44DE-BCAA-89BD4127A9AEQ35441308-115CD28B-8BFD-49C1-B59C-7CC33917ED19Q35594296-11C69B85-52A6-4967-AEA4-558FC0EA67E1Q35721948-3105B952-00A7-4268-8C0B-676D9AD9DC4CQ35838247-F694E63A-D29E-4BA5-8905-37FE4486A5D6Q35891861-08C55182-89C1-421A-9837-728DA84C4E06
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Biological therapies for inflammatory bowel diseases.
@en
Biological therapies for inflammatory bowel diseases.
@nl
type
label
Biological therapies for inflammatory bowel diseases.
@en
Biological therapies for inflammatory bowel diseases.
@nl
prefLabel
Biological therapies for inflammatory bowel diseases.
@en
Biological therapies for inflammatory bowel diseases.
@nl
P1433
P1476
Biological therapies for inflammatory bowel diseases.
@en
P2093
Severine Vermeire
P304
P356
10.1053/J.GASTRO.2009.02.001
P407
P577
2009-02-26T00:00:00Z